Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Shares Gap Down – Here’s Why

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) shares gapped down before the market opened on Tuesday . The stock had previously closed at $22.65, but opened at $21.08. Fresenius Medical Care AG & Co. KGaA shares last traded at $20.4280, with a volume of 541,188 shares.

Wall Street Analyst Weigh In

FMS has been the subject of a number of research analyst reports. Truist Financial set a $28.00 target price on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Monday, January 5th. Erste Group Bank cut Fresenius Medical Care AG & Co. KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 5th. The Goldman Sachs Group cut Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. Morgan Stanley restated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Tuesday, January 27th. Finally, Weiss Ratings cut Fresenius Medical Care AG & Co. KGaA from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, March 13th. Six analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Fresenius Medical Care AG & Co. KGaA currently has an average rating of “Reduce” and an average price target of $28.00.

Fresenius Medical Care AG & Co. KGaA Stock Performance

The stock has a 50-day simple moving average of $22.86 and a 200-day simple moving average of $23.56. The company has a market capitalization of $11.34 billion, a price-to-earnings ratio of 10.63, a price-to-earnings-growth ratio of 2.74 and a beta of 0.81. The company has a current ratio of 1.26, a quick ratio of 0.92 and a debt-to-equity ratio of 0.40.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last announced its earnings results on Saturday, February 14th. The company reported $1.69 earnings per share (EPS) for the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.73% and a net margin of 5.03%.The company had revenue of $5.95 billion for the quarter. On average, analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 2.45 earnings per share for the current year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The firm also recently announced an annual dividend, which will be paid on Monday, June 8th. Shareholders of record on Friday, May 22nd will be given a $0.8716 dividend. This represents a dividend yield of 385.0%. The ex-dividend date of this dividend is Friday, May 22nd. This is a positive change from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio is currently 29.84%.

Hedge Funds Weigh In On Fresenius Medical Care AG & Co. KGaA

Institutional investors have recently made changes to their positions in the business. Factory Mutual Insurance Co. acquired a new position in shares of Fresenius Medical Care AG & Co. KGaA in the 3rd quarter valued at approximately $1,769,000. Pzena Investment Management LLC lifted its stake in Fresenius Medical Care AG & Co. KGaA by 1.0% during the third quarter. Pzena Investment Management LLC now owns 14,816,852 shares of the company’s stock worth $390,128,000 after purchasing an additional 153,870 shares during the last quarter. Teachers Retirement System of The State of Kentucky lifted its stake in Fresenius Medical Care AG & Co. KGaA by 8.3% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 816,200 shares of the company’s stock worth $21,491,000 after purchasing an additional 62,700 shares during the last quarter. Todd Asset Management LLC lifted its stake in Fresenius Medical Care AG & Co. KGaA by 5.2% during the third quarter. Todd Asset Management LLC now owns 1,303,424 shares of the company’s stock worth $34,319,000 after purchasing an additional 64,311 shares during the last quarter. Finally, Moran Wealth Management LLC lifted its stake in Fresenius Medical Care AG & Co. KGaA by 67.4% during the fourth quarter. Moran Wealth Management LLC now owns 264,462 shares of the company’s stock worth $6,299,000 after purchasing an additional 106,438 shares during the last quarter. 8.37% of the stock is owned by institutional investors and hedge funds.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.